Kodiak Sciences Inc (NASDAQ: KOD) Stock Information | RedChip

Kodiak Sciences Inc (NASDAQ: KOD) Listen to this Section


$2.48
-0.1100 ( -4.25% ) 124.2K

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Market Data


Open


$2.48

Previous close


$2.59

Volume


124.2K

Market cap


$129.96M

Day range


$2.47 - $2.62

52 week range


$1.37 - $7.77

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 48 Nov 14, 2023
8-k 8K-related 12 Nov 06, 2023
8-k 8K-related 12 Aug 17, 2023
10-q Quarterly Reports 49 Aug 14, 2023
8-k 8K-related 13 Aug 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.